Publication: The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series)
Open/View Files
Date
2014
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
University of Chicago Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Lewis, Gregory D. 2014. “The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series).” Pulmonary Circulation 4 (3): 417-423. doi:10.1086/677369. http://dx.doi.org/10.1086/677369.
Research Data
Abstract
Abstract The functional and prognostic significance of pulmonary hypertension (PH) is well established, yet our understanding of circulating peptides and metabolites that might mark or contribute to various forms of PH remains limited. Metabolites are the end result of all the regulatory complexity present in a cell, tissue, or organism and therefore serve as the most proximal reporters of the body’s response to a disease process or drug therapy. This review presents the rationale, methodology, and preliminary findings from studies that apply comprehensive metabolite profiling to gain knowledge of new circulating markers of PH.
Description
Other Available Sources
Keywords
metabolite, pulmonary hypertension, exercise
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service